Journals / Erciyes Medical Journal / 2022 / Cilt: 44 - Sayı: 4

Evaluation of Serum Growth Arrest-Specific 6/ Soluble AXL Levels in Type 2 Diabetes Mellitus

Pages
411–415
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The Gas6, AXL, and sAXL concentrations were significantly lower in the patient group (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to investigate an association between serum growth arrest-specific 6 (Gas6), AXL, and soluble AXL (sAXL) levels and the glycosylated hemoglobin (HbA1c) and estimated glomerular filtration rate (eGFR) in diabetic patients.
📊
Key Findings & Data:Materials and Methods: This study included type 2 diabetes mellitus (T2DM) patients of a department of endocrinology and healthy individuals.
💡
Conclusion & Impact:The Gas6, AXL, and sAXL concentrations were significantly lower in the patient group (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study was to investigate an association between serum growth arrest-specific 6 (Gas6), AXL, and soluble AXL (sAXL) levels and the glycosylated hemoglobin (HbA1c) and estimated glomerular filtration rate (eGFR) in diabetic patients. Materials and Methods: This study included type 2 diabetes mellitus (T2DM) patients of a department of endocrinology and healthy individuals. The HbA1c and creatinine levels of all of the participants were evaluated using autoanalyzers and the eGFR was calculated according to the Chronic Kidney Disease Epidemiology Collaboration formula. The Gas6, AXL, and sAXL serum protein concentrations were analyzed using enzyme-linked immunosorbent assays. Results: The study group consisted of 51 patients (34 females and 17 males) diagnosed with T2DM and 17 healthy controls (9 females and 8 males). The Gas6, AXL, and sAXL concentrations were significantly lower in the patient group (p

🔖

Cite This Article

BAYRAM, F., ABEDİ, A. H., ÖZEL, M., BAŞKOL, G., SARAÇOĞLU, H., SUNGUR, N., ATICI, Y. (2022). Evaluation of Serum Growth Arrest-Specific 6/ Soluble AXL Levels in Type 2 Diabetes Mellitus. Erciyes Medical Journal, Cilt: 44 - Sayı: 4, 411–415. https://ajindex.com/articles/502139

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Vinik A, Flammer M. Diabetes and macrovascular disease. J Diabetes Complications 2002; 16: 235–45
  2. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 2019; 157: 107843
  3. Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomark Insights 2016; 11: 95–104
  4. Vicki F. Glucose and Hemoglobin A1c. Lab Medicine 2014; 45(1): e21–4
  5. Benett CM, Guo M, Dharmage SC. HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review. Diabet Med 2007; 24(3): 333–43
  6. Martín LB, García de Frutos P. Vitamin K-dependent actions of Gas6. Vitam Horm 2008; 78: 185–209
  7. Laurance S, Lemarié CA, Blostein MD. Growth arrest-specific gene 6 (gas6) and vascular hemostasis. Adv Nutr 2012; 3(2): 196–203. 8. van der Meer JH, van der Poll T, van ‘t Veer C. TAM receptors, Gas6, and protein S: roles in inflammation and hemostasis. Blood 2014; 123(16): 2460–9
  8. Tjwa M, Bellido-Martin L, Lin Y, Lutgens E, Plaisance S, Bono F, et al. Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes. Blood 2008; 111(8): 4096– 105
  9. Ekman C, Stenhoff J, Dahlbäck B. Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood. J Thromb Haemost 2010; 8(4): 838–44
  10. Holstein E, Binder M, Mikulits W. Dynamics of AXL receptor shedding in hepatocellular carcinoma and its implication for theranostics. Int J Mol Sci 2018; 19(12): 4111
  11. Lee CH, Changchien CY, Hung YJ. Targeting inflammation in type 2 diabetes by antibody-mediated Tyro-3, Axl, Mer receptor activation. J Diabetes Investig 2015; 6(5): 491–4
  12. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150(9): 604–12
  13. Stenberg LM, Nilsson E, Ljungberg O, Stenflo J, Brown MA. Synthesis of gamma-carboxylated polypeptides by alpha-cells of the pancreatic islets. Biochem Biophys Res Commun. 2001; 283(2): 454–9
  14. Dihingia A, Kalita J, Manna P. Implication of a novel Gla-containing protein, Gas6 in the pathogenesis of insulin resistance, impaired glucose homeostasis, and inflammation: A